ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Novel Combination of Silver Nanoparticles and Carbon Nanotubes for Plasmonic Photo Thermal Therapy in Melanoma Cancer Model

Mohammad Ali Behnam, Farzin Emami, Zahra Sobhani*, Omid Koohi-Hosseinabadi, Amir Reza Dehghanian, Seyed Mojtaba Zebarjad, Mohammad Hadi Moghim, Ahmad Oryan

Adv Pharm Bull. 2018;8(1): 49-55. doi: 10.15171/apb.2018.006

PMCID: PMC5896395 PMID: 29670838 Scopus ID: 85044086246

Article

PDF

XML

Cited By:

Research Article

2. Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer In Vitro

Nasim Dana , Golnaz Vaseghi , Shaghayegh Haghjooy Javanmard*

Adv Pharm Bull. 2020;10(3): 458-463. doi: 10.34172/apb.2020.056

PMCID: PMC7335991 PMID: 32665906 Scopus ID: 85088612515

Article

PDF

Full Text

XML

Cited By:

Research Article

3. Co-Administration of Vadimezan and Recombinant Coagulase-NGR Inhibits Growth of Melanoma Tumor in Mice

Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Davoud Farajzadeh, Ramezan Behzadi, Nosratollah Zarghami*

Adv Pharm Bull. 2021;11(2): 385-392. doi: 10.34172/apb.2021.037

PMCID: PMC8046391 PMID: 33880362 Scopus ID: 85103213880

Article

PDF

Full Text

XML

Cited By:

Research Article

4. Melanoma Cancer Therapy Using PEGylated Nanoparticles and Semiconductor Laser

Abdorreza Asrar , Zahra Sobhani , Mohammad Ali Behnam*

Adv Pharm Bull. 2022;12(3): 524-530. doi: 10.34172/apb.2022.055

PMCID: PMC9348541 PMID: 35935047 Scopus ID: 85140274726

Article

PDF

Full Text

XML

Cited By:

Research Article

5. Cytotoxicity Induced by Newly Synthesized Palladium (II) Complexes Lead to the Death of MCF-7 and MDA-MB-435 Cancer Cell Lines

Bruna Alexandre Oliveira da Silva* , Isabela Spido Dias , Luís Eduardo Sarto , Elba Pereira de Gois , Claudia Torres , Eduardo Tonon de Almeida , Cibele Marli Cação Paiva Gouvêa

Adv Pharm Bull. 2023;13(1): 160-169. doi: 10.34172/apb.2023.017

PMCID: PMC9871269 PMID: 36721806

Article

PDF

Full Text

XML

Cited By:

Research Article

6. Liposome-Fe3 O4-Doxorubicin Mediated Treatment of Melanoma Tumors

Azalia Azlegini , Sirus Javadpour* , Mohamad Ebrahim Bahrololoom

Adv Pharm Bull. 2023;13(2): 309-316. doi: 10.34172/apb.2023.034

PMCID: PMC10278224 PMID: 37342384

Article

PDF

Full Text

XML

Cited By:

Review Article

7. Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma

Zahra Saeidi , Rashin Giti, Mehdi Rostami, Farhad Mohammadi*

Adv Pharm Bull. 2023;13(4): 646-662. doi: 10.34172/apb.2023.070

PMCID: PMC10676549 PMID: 38022807

Article

PDF

Full Text

XML

Cited By: